Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-22-023498
Date:2022-06-17
Issuer: ATEA PHARMACEUTICALS, INC. (AVIR)
Original Submission Date:

Reporting Person:

LUCIDI BRUNO
225 FRANKLIN STREET
SUITE 2100 BOSTON, MA 02110

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.5 2022-06-17 deemed execution date A 61,264 (a) 2032-06-16 common stock 61,264 $6.50 61,264 direct
Footnotes
IDfootnote
f1 the option vests and becomes exercisable in twelve (12) equal monthly installments following june 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the reporting person's continued service through each such vesting date.

Elevate your investments